Patents by Inventor Florian Tomszak

Florian Tomszak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy
    Publication number: 20230338424
    Abstract: Chimeric antigen receptors containing CD123 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.
    Type: Application
    Filed: January 13, 2023
    Publication date: October 26, 2023
    Inventors: Dina Schneider, Zhongyu Zhu, Florian Tomszak, Rafijul Bari
  • Compositions and methods for treating cancer with anti-CD123 immunotherapy
    Patent number: 11590169
    Abstract: Chimeric antigen receptors containing CD123 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: February 28, 2023
    Assignee: LENTIGEN TECHNOLOGY, INC.
    Inventors: Dina Schneider, Zhongyu Zhu, Florian Tomszak, Rafijul Bari